Our Team

v.Labs USA Leadership

T. Allan McArtor
Chairman

T. Allan McArtor serves as Vigilent Labs Chairman of the Board. Mr. McArtor recently retired as Chairman Airbus Americas, Inc. Named as Chairman in 2001, McArtor was responsible for all Airbus business in the Americas. Before joining Airbus, McArtor was founder and CEO of Legend Airlines. From 1979 to 1994,

McArtor was SVP Air Operations for Federal Express, except for two years 1987 to 1989, when President Ronald Reagan appointed McArtor to serve as Administrator for the Federal Aviation Administration (FAA). McArtor is a 1964 graduate of the U.S. Air Force Academy (BSE), was the Cadet Wing Commander, and a former USAF fighter pilot. He holds a Master’s degree (MSE) from Arizona State University. 

Tina W. Jonas
Board Member

Ms. Jonas is an executive with a distinguished career in government and the private sector. A recognized expert in military and defense issues, Ms. Jonas served more than two decades in government including as Undersecretary of Defense (CFO/Comptroller) for the Department of Defense. Her corporate experience includes serving as an operations executive with United Technologies and Sikorsky Aircraft. Most recently, she served as an executive with UnitedHealth Group, as President of UnitedHealthcare, Military and Veterans, and Senior Vice President, Operations for Optum. Ms. Jonas is currently an independent consultant and serves on several Board of Directors in the Defense and Aerospace sectors.

John M. Falk
President and Board Member

Mr. Falk serves as Vigilent Labs President. He is the Founder and President of Vigilent Inc. Falk’s work in Bio-Terrorism & Bio-Surveillance began in 2003 when he first launched VIGILENT embracing and extending the “LEADERS” Concept built by the U.S.Air Force. Mr. Falk also developed the concept of v.BDNS (Bio-defense digital nervous system) as a comprehensive Bio-Terrorism Threat Response-solution. Mr. Falk started Vigilent Inc. to bring forward C5ISR Solutions, Interoperable Command & Control solutions and new Bio-Surveillance Screening & Testing systems with the latest in Sensor Fusion for the Public Safety, Public Health, Defense, Homeland Security, Law Enforcement and the First Responder community.

Mr. Falk is a proven expert with interoperable communications for rapid command & control systems with sensor-fusion and advanced data analytics. In 2017, he was appointed to the Aviation Committee of the International Association of Chief’s of Police and since 2014 has served as an Adjunct Professor of Law at George Washington University School of Law.

v.Labs Management Team

Todd A. Ritter
Chief Technology Officer

Mr. Ritter serves as the Chief Technology Officer for Vigilent Labs.  He has spent his career as an innovator in medical surveillance.  A Captain in the USAF and the Chief of Medical Force Protection at Air Combat Command, Langley AFB, Mr. Ritter developed several novel medical surveillance systems. that integrated various data sets to include laboratory data, bio-environmental data and weather with geolocation of the data sources.  In addition, he developed the Ruggedized Advanced Pathogen Identification Device that was selected to be the Joint Biological Agent Identification Device or JBAIDS.  After leaving the USAF in 2000, Mr. Ritter joined start up biotechnology company Idaho Technology.  Where he led the development and deployment of four complete FDA approved diagnostic platforms that are still in use today in most hospitals around the world.

Mr. Ritter moved on to the Defense Threat Reduction Agency (DTRA) His duties included directing validation and technology transfer from federal R&D agencies, such as DARPA and AFRL, to various field agencies to include JPO Chem/Bio Defense.  His focus was on field deployable, easy-to-use biological testing solutions.

In 2015 Mr. Ritter joined Genalyte as the Director of Products and Corporate Development where he Directed four cross-company teams nationally and globally to develop strategies for a broad array of technology applications in pharmaceuticals, medical devices and diagnostics, biotechnology for  payers and providers. Achieved the Institutional Clinical Laboratory Improvement Amendments (CLIA) Certification to ensure quality laboratory testing standards and secured $42 Million in research and development funding from private investment firms.

Laila Samady-Mustad, Ph.D
Chief Scientific Officer
Director, Board of Advisors

With a PhD in Molecular Pathology and Immunology from University College London (UCL), Dr. Samady-Mustad has 20 years’ experience both academically and in the pharmaceutical, medical technology and biotechnology industry in cancer research and therapeutics in the UK, France and in the US, with expertise in medical affairs, partnerships, business development and capital raising strategies. Based in London, she is working as strategic advisor, Vice-President, Business Development for two companies, Covanos Inc., a development stage medical technology company focusing on computational vascular diagnostics and Global Genomics Group (G3 Therapeutics), a biotechnology company with expertise in life sciences and medical disciplines, artificial intelligence and data computing.

Dr. Samady-Mustad’s work at UCL led to the development of patents and a spin out company, BioVex, acquired by Amgen in 2011 for $1B. While at Boehringer Ingelheim, she served in increasingly senior roles initially in cardiovascular medical affairs leading to a global strategic role in oncology medical affairs and Global Trial Alliance Manager. Prior to her PhD, she obtained a BSc in Biochemistry at Trinity College, Hartford, CT and MSc in Molecular and Cell Biology from Institut Pasteur, Paris.

Kenneth W. Rousseau
Chief Operating Officer, Government Programs

Mr. Rousseau serves as Vigilent Labs Chief Operating Officer. He has over 48 years experience in the Government market space and specifically the Department of Defense (DoD). Thirty-five years of this experience has been focused on providing business development, proposal management and technical writing including solution development for Training Systems, Professional Services, Custom Manufacturing, and Information Technology (IT) products and services to Federal and State Government as well as commercial customers nationwide. Mr. Rousseau has extensive experience managing programs of all sizes from 1 million to 45 million dollars with durations ranging from 6 months to 7 years. He performed in corporate operations and business development roles for small and large businesses and has significantly contributed to the successful transition of several Small Disadvantaged Businesses to the full and open competitive environment

In 2002, Mr. Rousseau founded Integrated Knowledge Solutions and Information Technology (IKSIT) as a proposal support services company focused on leveraging company technical and proposal data to provide a winning solution. He developed a Knowledge Management (KM) solution that enhanced internal company proposal processes through combining data mining and workflow principles with the standard business development and marketing paradigms.

Dave Parikh
Chief Financial Officer

Mr Parikh has over fifteen years of experience in areas of Investing, Consulting and Investment Banking, during which, he has advised middle-market clients in areas of M&A, Debt and Equity Issuance, Recapitalization, ESOPs, Strategic Planning, Pricing and Budgeting, Risk Management, Compliance with regulations set forth by DCAA, SBA, and lending institutions, establishment of Strong Internal Control Policies and Procedures in regards to Financial Reporting, Management and Growth and Profitability Maximization.

During his banking tenure, Mr Parikh has successfully structured over 100 financing transactions, ranging from $1M to $300M primarily in the Government, Defense, & Aerospace industry.

He has used his expertise in Financial & Management Accounting, DCAA Regulations and FAR Accounting , expertise in all major Accounting Systems, Job Costing & Financial Modeling, Budgeting & Forecasting, and Tax strategies to help turnaround several unprofitable and stagnant companies into financially successful organizations.

Mr Parikh has founded, invested in, and exited several businesses in fields of defence and financial services.

Mr Parikh is fluent in over seven languages and has worked or lived in nine countries.

v.Labs Board of Advisors

General T. Michael “Buzz” Moseley
Military Advisor

(Ret.) General T. Michael Moseley, served as Chief of Staff of the U.S. Air Force, Washington, D.C. As Chief, he was the senior uniformed Air Force officer responsible for the organization, training and equipage of nearly 700,000 active-duty, Guard, Reserve and civilian forces serving in the United States and overseas. As a member of the Joint Chiefs of Staff, the general and other service chiefs function as military advisers to the Secretary of Defense, National Security Council and the President.

Robert K. Lunday, Jr. (Bob) 
Senior Investment Advisor

After retirement as a U.S. Marine Corps Officer, Bob transitioned to a career in international business, and for 25 years he was dedicated to the defense and security of the United Arab Emirates (UAE). Bob worked numerous international programs involving Space, Defense, Aerospace, Program Management, Contract Negotiations, Offsets, Business Development, Pilot Training, Healthcare, Administration and Human Resources and was directly involved in winning international contracts in excess of USD 14 billion. During those years he was Acting Chief of the US Embassy Military Liaison Office in Abu Dhabi, Senior Advisor and Chief Pilot for the UAE Air Force and Air Defense, Managing Director McDonnell Douglas Middle East Abu Dhabi, Customer interface and Pilot Training Lead for the Lockheed Martin Aerospace UAE F-16 Block 60 Program, Director of HR and Administration for Zayed Military Hospital, Regional Executive and Country Manager for Raytheon International Middle East, North Africa and Pakistan, Chief Liaison Officer and Senior Advisor for Emirates Advanced Investments Group Abu Dhabi, and Mentor to numerous CEOs and GMs to the region.

Bob served on the Board of Directors for AmCham Abu Dhabi for eight years. As a board member, Bob was honored to represent 450 US companies in the UAE for six years on “Door Knocks” to the U.S. Congress and U.S. Governors promoting trade between the United Arab Emirates and the United States of America. 

Bob is a graduate of Oklahoma State University, the Defense Institute of Security Assistance Management, the Defense Systems Management College, USMC Command & Staff College, and Marine Aviation Weapons and Tactics Squadron(MAWTS-1).

Habib Samady, M.D.
Senior Technical Advisor 

Dr. Samady is Professor of Medicine and Director of Interventional Cardiology for the Emory University Hospital System. He also is the founding director of the Emory Cardiovascular Imaging and Biomechanical Core Laboratory. He is recognized as one of the foremost international experts in coronary physiology. He has an actively funded clinical and translational research program, is extensively published with over 350 publications and abstracts in intravascular imaging, coronary physiology, atherosclerosis assessment, and stent biomechanics. He has supervised and participated in training over 70 interventional and 120 general cardiology fellows. He is on the editorial board of

numerous cardiovascular journals, serves as Deputy Editor of the Journal of American College of Cardiology Cardiovascular Interventions, and is a co-Editor of a major textbook, Interventional Cardiology, 2nd Ed., McGraw Hill, 2017. Dr. Samady directs the Emory Practical Interventional Course Southeastern Consortium (EPIC-SEC), which is a 25member clinical, educational and research consortium of academic medical centers consortium with a large annual continuing medical education course (www.epicsec.org).

On the entrepreneurial front, Dr. Samady is co-Founder and Chief Medical Officer of Covanos Inc., a computational diagnostic cardiovascular imaging company. He also is on the steering committee of numerous international clinical trials related to intravascular imaging and physiology and is a consultant to several medical technology and biotechnology companies including Philips and Abbott

Vascular.

Richard L. Dunn
Procurement/OTA Advisor

Mr. Dunn provides advice and engages in research and analysis related to the deployment and implementation of technology in the military and civil sectors through partnering and other innovative means; he conducts research in national security operations, technology and their interactions; and, analyzes laws, policies and practices that impact the effective implementation of technology. He is founder and consultant at Strategic Institute for Innovation in Government Contracting. He served as Expert-Consultant at National Defense University, 2016–2017. Pro bono work has included appointment to several study groups of the National Academy of Science and Defense Science Board. He serves as a trustee of the Chesapeake Environmental Protection Association.

Lewis W. Crenshaw
Medical Technology Advisor

Mr. Crenshaw serves as Senior Advisor to Vigilent Labs.  He is an expert in the engineering and manufacturing of FDA Registered and Approved medical deices. Mr. Crenshaw has managed development of Class II medical devices including regulatory pathway, device engineering, quality system and Clinical Investigation Plan to the Food & Drug Administration (FDA). Mr. Crenshaw and his team won a key contract over multiple established defense contractors to design and install next generation man overboard alerting system for the US Naval fleet.

Mr. Crenshaw is the Co-Founder and COO of TC Medical Co., Medical device engineering and regulatory consulting company specializing in venture funded medical device development.

Andrew Finn
Financial Advisor

Mr.Finn servers as Vigilent Labs Financial Advisor. He as spent the balance of his 23 years of professional operational and management experience in the aerospace and defense industry. Andy is called upon to provide highly analytical guidance to companies both domestic and international.

An Empowered Official, Andy is quite knowledgeable about ITAR having worked extensively with the US Department of State related to import and export of products including: firearms, ammunition, electro-optic payloads, sensors, aircraft and armor among other products. He has designed and executed international business expansion strategies for several companies with countries in the Middle East, Europe and Asia. 

Mr. Finn’s previous work experience includes operating within the International Defense Group at PricewaterhouseCoopers LLP, providing financial guidance to US and foreign federal entities including NATO. 

v.Labs USA & v.Labs Contacts

John M. Falk
President
(202) 215-9511
jmf@vigilent-inc.com
jmf@vigilentlabs.com